Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CGS International Securities (formerly CGS-CIMB Securities) is a leading integrated financial services provider and investment bank in Asia. Headquartered in Singapore, the company offers a comprehensive suite of services including equities trading, wealth management, investment banking, equities research, and prime brokerage across more than 15 countries and regions. Wholly owned by China Galaxy Securities, a top-tier Chinese securities firm, CGS International serves as a critical bridge facilitating cross-border capital flows and investment collaborations between China and the ASEAN region. While primarily a financial institution, the firm maintains a strong presence in the healthcare and biotechnology sectors through dedicated equity research, market analysis, and advisory services for healthcare capital market activities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CGS International.